Literature DB >> 9587576

[Color Doppler ultrasonography in retinitis pigmentosa. Preliminary study].

M Cellini1, R Lodi, G L Possati, M Sbrocca, D Pelle, N Giubilei.   

Abstract

PURPOSE: Retinitis pigmentosa is a bilateral retinal degeneration. The primary disorder is still debated.
METHODS: We performed a prospective investigation of the ocular circulation directly by color Doppler imaging (CDI). A total of 28 eyes of 14 patients (8 men and 6 women, affected with retinitis pigmentosa) were recruited for this study. For each case were evaluated protosystolic velocity and the resistive index of the ophthalmic artery, central retinal artery, posterior ciliary arteries and choroid. These values, furthermore, have been compared with a control group.
RESULTS: The results of the CDI in the group of RP and in the CG were: in the OA: PSV 31.177 +/- 5.119 cm/sec vs 36.700 +/- 3.152 cm/sec (p < 0.007); RI 0.713 +/- 0.058 vs 0.717 +/- 0.019 (p < 0.0839); in the CRA PSV 7.075 +/- 1.611 cm/sec vs 12.710 +/- 2.795 cm/sec (p < 0.001); RI 0.560 +/- 0.062 vs 0.550 +/- 0.051 (p < 0.234); in the PCA: PSV 8.569 +/- 3.408 cm/sec vs 14.100 +/- 2.571 cm/sec (p < 0.001) with RI 0.634 +/- 0.090 vs 0.681 +/- 0.045 (p < 0.145). In the CHO: PSV 12.312 +/- 2.327 cm/sec vs 16.170 +/- 1.846 cm/sec (p < 0.001) with RI 0.581 +/- 0.072 vs 0.638 +/- 0.050 (p < 0.065).
CONCLUSION: Our results suggest that in the affected eyes there is a statistically significant reduction in blood flow in ophthalmic and ciliary arteries. These data offer new views on the retinitis cause of pigmentosa and possible therapeutics to be studied.

Entities:  

Mesh:

Year:  1997        PMID: 9587576

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  8 in total

1.  Retinal vessel oxygen saturation and vessel diameter in retinitis pigmentosa at various ages.

Authors:  Yao Zong; Leilei Lin; Changxian Yi; Xia Huang; Yue Fu; Yanmin Dong; Xiaobing Qian; Yujie Li; Qianying Gao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-08       Impact factor: 3.117

2.  The impact of macular edema on microvascular and metabolic alterations in retinitis pigmentosa.

Authors:  Margarita G Todorova; Hendrik P N Scholl; Maria Della Volpe Waizel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-10       Impact factor: 3.117

3.  Projection-Resolved Optical Coherence Tomographic Angiography of Retinal Plexuses in Retinitis Pigmentosa.

Authors:  Ahmed M Hagag; Jie Wang; Kevin Lu; Gareth Harman; Richard G Weleber; David Huang; Paul Yang; Mark E Pennesi; Yali Jia
Journal:  Am J Ophthalmol       Date:  2019-03-06       Impact factor: 5.258

4.  Retinal Vascular Abnormalities in Different Types of Inherited Retinal Dystrophies Assessed by Optical Coherence Tomography Angiography.

Authors:  Hamideh Sabbaghi; Narsis Daftarian; Kiana Hassanpour; Sahba Fekri; Ramin Nourinia; Fatemeh Suri; Bahareh Kheiri; Mehdi Yaseri; Mojtaba Rajabpour; Kourosh Sheibani; Hamid Ahmadieh
Journal:  J Curr Ophthalmol       Date:  2021-07-05

5.  ET-1 Plasma Levels, Aqueous Flare, and Choroidal Thickness in Patients with Retinitis Pigmentosa.

Authors:  Ernesto Strobbe; Mauro Cellini; Michela Fresina; Emilio C Campos
Journal:  J Ophthalmol       Date:  2015-06-02       Impact factor: 1.909

6.  Cone Dystrophies: An Optical Coherence Tomography Angiography Study.

Authors:  Lisa Toto; Maurizio Battaglia Parodi; Rossella D'Aloisio; Stefano Mercuri; Alfonso Senatore; Luca Di Antonio; Guido Di Marzio; Marta Di Nicola; Rodolfo Mastropasqua
Journal:  J Clin Med       Date:  2020-05-16       Impact factor: 4.241

Review 7.  The Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis Pigmentosa.

Authors:  Francesco Saverio Sorrentino; Claudio Bonifazzi; Paolo Perri
Journal:  J Ophthalmol       Date:  2015-11-03       Impact factor: 1.909

8.  Acupuncture benefits for Flammer syndrome in individuals with inherited diseases of the retina.

Authors:  Tilo Blechschmidt; Maike Krumsiek; Margarita G Todorova
Journal:  EPMA J       Date:  2017-05-31       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.